North America ELISpot and FluoroSpot Assay Market Outlook: Growth Opportunities in Immunological Research North America is expected to remain a significant region in the ELISpot and FluoroSpot Assay Market through 2034, supported by the region’s advanced biotechnology and life sciences infrastructure. The presence of leading research institutions, pharmaceutical companies, biotechnology firms, and specialized laboratories is driving the adoption of immune-monitoring technologies. ELISpot and FluoroSpot assays are increasingly used for evaluating cellular immune responses in infectious disease research, vaccine development, cancer immunology, autoimmune disease studies, and clinical research. Read More - https://www.theinsightpartners.com/reports/elispot-and-fluorospot-assay-market